2 products were found matching "1414386-05-2"!

No results were found for the filter!
NEW
Anti-IL-17A/F and Serum Albumin Nanobody (Sonelokimab)
Anti-IL-17A/F and Serum Albumin Nanobody (Sonelokimab)

Item number: BPS-84254-1

Sonelokimab, also known as ALX 076,1 is a trivalent bispecific nanobody composed of camel derived humanized IL-17 F antibodies, IL-17A/F antibodies, and serum albumin VHH antibodies. Sonelokimab can prolong the plasma half-life by binding to human serum albumin. Sonelokimab can be used for research on rheumatoid...
Keywords: IL17A, Interleukin-17A, Cytotoxic T-lymphocyte-associated antigen 8
Application: ELISA, FC, FA
Host: Human
CAS 1414386-05-2
From 1,646.00€ *
Review
Sonelokimab
Sonelokimab

Item number: TGM-T76885-5mg

Description: Sonelokimab (ALX 0761, M 1095) is a trivalent nanobody combining monovalent camelid-derived nanobodies targeting human interleukin (IL)-17A and IL-17F with human serum albumin VHHs, presenting it as a promising candidate for investigating plaque-type psoriasis treatments [1] [2].
CAS 1414386-05-2
1,308.00€ *
Review